Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07809867) titled 'Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: Istituto Giannina Gaslini

Condition: Cystic Fibrosis (CF)

Intervention: Drug: Elexacaftor, Tezacaftor, Ivacaftor

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: September 2026

Target Sample Size: 50

To know more, visit https://clinicaltrials.gov/study/NCT07809867

Published by HT Digital Content Services with permission f...